Evidence map›Paper›PMID 42340351›Full record

ArticleCancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology2026

No Association of Prior Administration of Selected Vaccines with Lymphoma Prognosis.

George A Cholack, Verena Hinder, Raphael Mwangi, Thomas M Habermann, Dennis P Robinson, Melissa C Larson, Andrew L Feldman, Thomas E Witzig, Stephen M Ansell, Eric Mou and 6 more

Abstract read
In one paragraph

Article in Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

George A Cholack *Department of Internal Medicine, Mayo Clinic School of Graduate Medical Education, Rochester, Minnesota.ORCID 0000-0001-6774-7326
Verena Hinder *Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0006-3795-2269
Raphael MwangiDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-9004-9099
Thomas M HabermannDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-3532-9132
Dennis P RobinsonDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0009-0000-4812-9397
Melissa C LarsonDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-5430-8161
Andrew L FeldmanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0001-5009-4808
Thomas E WitzigDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-4215-6500
Stephen M AnsellDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0003-1244-6758
Eric MouDivision of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, Iowa.ORCID 0000-0002-9865-4517
Yucai WangDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-1576-8341
Carrie A ThompsonDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-4518-2309
Matthew J MaurerDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-1867-0526
Anne J NovakDivision of Hematology, Department of Medicine, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-7904-1651
Susan L SlagerDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-5173-4712
James R CerhanDepartment of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-7482-178X

Funding

The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI LINK, BRIAN K. · 2002 to 2021
$45.7M
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Supplement)U01CA195568 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R, FLOWERS, CHRISTOPHER R · 2015 to 2025
$22.1M
The Lymphoma Epidemiology of Outcomes (LEO) Cohort StudyU01CA308978 · NCI · MAYO CLINIC ROCHESTER · PI JAMES R CERHAN, CHRISTOPHER R FLOWERS · 2026 to 2026
$1.3M
National Cancer Institute (NCI) P50 CA97274National Cancer Institute (NCI) U01 CA195568NCI NIH HHS P50 CA097274NCI NIH HHS U01 CA195568NCI NIH HHS U01 CA308978
6 · The paper itself

Abstract

backgroundAlthough some vaccines seem to be associated with a lower risk of lymphoma, their impact on outcomes is largely unknown.

methodsData from a large prospective lymphoma cohort study were utilized to estimate associations of self-reported history of vaccination against hepatitis A, hepatitis B, influenza, and yellow fever with event-free survival (EFS) and overall survival (OS) using Cox proportional hazard models.

resultsNone of the vaccines were associated with EFS [hazard ratio (HR) 0.77-1] or OS (HRs 0.96-1.04). Similarly, there were no significant associations between the vaccines and outcomes for each lymphoma subtype.

conclusionsPrior vaccination against selected viruses was not associated with EFS or OS among patients with lymphoma. IMPACT: We did not find evidence for an impact of prior vaccination on lymphoma prognosis.

Indexed as

LymphomaVaccinationAdultAgedFemaleHumansMaleMiddle AgedPrognosisProspective Studies

Identifiers

PMID42340351
PMCPMC13383572

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.